Unlocking Nano-Drug Potential: Revolutionizing In Vitro Dissolution Testing for Nanomedicines

Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

In-vitro dissolution study is crucial for quality assurance and stability, serving as a surrogate test for evaluating in-vivo performance of a drug. The dissolution procedure should be designed using an appropriate validated approach, depending on the type of dosage form. Dissolution testing is crucial to regulatory decision-making in a number of aspects. Conventional formulations have validated regulatory-compliant dissolution methods, conversely novel drug formulations like nanoparticles and microparticles lack standard validated procedures for the same. The present article provides information about the various compendial and non-compendial methods available for in-vitro dissolution testing of nano-formulations including the selection of dissolution media, different factors affecting the release, advancements in the dissolution procedures and also included the recently developed marketed nano-formulations.

Article activity feed